Osilodrostat in Cushing's disease: The risk of delayed adrenal insufficiency should be carefully monitored

Frederic Castinetti (1, 2, 3) , Vincent Amodru (1, 2) , Thierry Brue (1, 2, 3)

1 MMG - Marseille medical genetics - Centre de génétique médicale de Marseille
2 MarMaRa - Institut Marseille Maladies Rares
3 Service d'endocrinologie, diabète, maladies métaboliques [Hôpital de la Conception - APHM]

Domaines: Médecine humaine et pathologie

Frederic Castinetti, Vincent Amodru, Thierry Brue. Osilodrostat in Cushing's disease: The risk of delayed adrenal insufficiency should be carefully monitored. Clinical Endocrinology, 2021, ⟨10.1111/cen.14551⟩. ⟨hal-03660863⟩